NO20075148L - Anti-proliferativ kombinasjonsterapi med andvendelse av visse platinum-baserte kjemoterapeutiske midler og taxaner - Google Patents

Anti-proliferativ kombinasjonsterapi med andvendelse av visse platinum-baserte kjemoterapeutiske midler og taxaner

Info

Publication number
NO20075148L
NO20075148L NO20075148A NO20075148A NO20075148L NO 20075148 L NO20075148 L NO 20075148L NO 20075148 A NO20075148 A NO 20075148A NO 20075148 A NO20075148 A NO 20075148A NO 20075148 L NO20075148 L NO 20075148L
Authority
NO
Norway
Prior art keywords
combination therapy
chemotherapeutic agents
taxanes
based chemotherapeutic
certain platinum
Prior art date
Application number
NO20075148A
Other languages
English (en)
Norwegian (no)
Inventor
Katja Wosikowski-Buters
Hermanshu Shah
Maureen Caligiuri
Original Assignee
Gpc Biotech Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gpc Biotech Ag filed Critical Gpc Biotech Ag
Publication of NO20075148L publication Critical patent/NO20075148L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/282—Platinum compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO20075148A 2005-03-11 2007-10-10 Anti-proliferativ kombinasjonsterapi med andvendelse av visse platinum-baserte kjemoterapeutiske midler og taxaner NO20075148L (no)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP05005380A EP1700598B1 (fr) 2005-03-11 2005-03-11 Therapie anti-proliférative combinée avec le satraplatine ou JM118 et le docetaxel
US66409605P 2005-03-21 2005-03-21
US73554705P 2005-11-10 2005-11-10
PCT/EP2006/060615 WO2006095016A2 (fr) 2005-03-11 2006-03-10 Traitement combine antiproliferatif utilisant certains agents chimiotherapeutiques a base de platine et des taxanes

Publications (1)

Publication Number Publication Date
NO20075148L true NO20075148L (no) 2007-12-07

Family

ID=34934212

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20075148A NO20075148L (no) 2005-03-11 2007-10-10 Anti-proliferativ kombinasjonsterapi med andvendelse av visse platinum-baserte kjemoterapeutiske midler og taxaner

Country Status (16)

Country Link
US (1) US20090030067A1 (fr)
EP (2) EP1700598B1 (fr)
JP (1) JP2008532982A (fr)
CN (1) CN101137360A (fr)
AR (1) AR053338A1 (fr)
AT (1) ATE431140T1 (fr)
AU (1) AU2006221964A1 (fr)
CA (1) CA2600558A1 (fr)
DE (1) DE602005014442D1 (fr)
DK (1) DK1700598T3 (fr)
ES (1) ES2327421T3 (fr)
IL (1) IL185679A0 (fr)
NO (1) NO20075148L (fr)
TW (1) TW200642684A (fr)
WO (1) WO2006095016A2 (fr)
ZA (1) ZA200708128B (fr)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ300424B6 (cs) * 2006-06-20 2009-05-13 Pliva - Lachema A. S. Farmaceutická kompozice pro perorální podání
CZ300120B6 (cs) * 2006-06-20 2009-02-11 Pliva - Lachema A. S. Farmaceutická kompozice pro injekcní podání
EP1905437A1 (fr) * 2006-09-24 2008-04-02 GPC Biotech AG Traitement de la douleur à l'aide de la satraplatine
EP1905439A1 (fr) * 2006-09-24 2008-04-02 GPC Biotech AG Traitement de second niveau du cancer de la prostate réfractaire à hormone métastatique en utilisant de la satraplatine
WO2010121243A1 (fr) * 2009-04-17 2010-10-21 University Of Arizona Composés, compositions pharmaceutiques et procédés d'utilisation de 2-aryl-pyridylazoles
US8481498B1 (en) 2012-01-17 2013-07-09 Steven Hoffman Pharmaceutical compositions and methods
US10272068B2 (en) 2012-01-17 2019-04-30 Tyme, Inc. Pharmaceutical compositions and methods
US20130183263A1 (en) 2012-01-17 2013-07-18 Steven Hoffman Pharmaceutical compositions and methods
BR112014017613A2 (pt) * 2012-01-17 2017-07-04 Tyme Inc composição farmacêutica, kit, método para tratar câncer em um indivíduo e método para reduzir a proliferação celular em um indivíduo
US10646552B2 (en) 2012-01-17 2020-05-12 Tyme, Inc. Pharmaceutical compositions and methods
US9763903B2 (en) 2013-10-22 2017-09-19 Steven Hoffman Compositions and methods for treating intestinal hyperpermeability
US9585841B2 (en) 2013-10-22 2017-03-07 Tyme, Inc. Tyrosine derivatives and compositions comprising them
US9326962B2 (en) 2013-10-22 2016-05-03 Steven Hoffman Compositions and methods for treating intestinal hyperpermeability
US10751313B2 (en) 2013-10-22 2020-08-25 Yamo Pharmaceuticals Llc Compositions and methods for treating autism
US10813901B2 (en) 2013-10-22 2020-10-27 Yamo Pharmaceuticals Llc Compositions and methods for treating autism
CN107635574B (zh) 2015-03-30 2021-12-28 桑尼布鲁克研究院 治疗癌症的方法
US10169325B2 (en) 2017-02-09 2019-01-01 International Business Machines Corporation Segmenting and interpreting a document, and relocating document fragments to corresponding sections
WO2021046453A1 (fr) 2019-09-06 2021-03-11 Eta Wireless, Inc. Commande de gestion de puissance sur une ligne de transmission pour ensembles de puces à ondes millimétriques pour radios cellulaires

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4683195A (en) 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
US6025473A (en) * 1992-10-27 2000-02-15 Queen's University At Kingston Multidrug resistance proteins
US20040072889A1 (en) * 1997-04-21 2004-04-15 Pharmacia Corporation Method of using a COX-2 inhibitor and an alkylating-type antineoplastic agent as a combination therapy in the treatment of neoplasia
CA2307393A1 (fr) * 2000-05-01 2001-11-01 The University Of British Columbia Chimiotherapie par administration d'un ginsenoside
US20060205810A1 (en) * 2004-11-24 2006-09-14 Schering Corporation Platinum therapeutic combinations

Also Published As

Publication number Publication date
EP1700598A1 (fr) 2006-09-13
AR053338A1 (es) 2007-05-02
DK1700598T3 (da) 2009-08-31
IL185679A0 (en) 2008-08-07
TW200642684A (en) 2006-12-16
AU2006221964A1 (en) 2006-09-14
ZA200708128B (en) 2008-10-29
CN101137360A (zh) 2008-03-05
ES2327421T3 (es) 2009-10-29
DE602005014442D1 (de) 2009-06-25
US20090030067A1 (en) 2009-01-29
WO2006095016A3 (fr) 2007-05-10
ATE431140T1 (de) 2009-05-15
EP1700598B1 (fr) 2009-05-13
WO2006095016A2 (fr) 2006-09-14
JP2008532982A (ja) 2008-08-21
CA2600558A1 (fr) 2006-09-14
EP1861086A2 (fr) 2007-12-05

Similar Documents

Publication Publication Date Title
NO20075148L (no) Anti-proliferativ kombinasjonsterapi med andvendelse av visse platinum-baserte kjemoterapeutiske midler og taxaner
TR200906131T1 (tr) Aktivin -actrIIa antagonistleri ve göğüs kanserinin tedavi e
NO20074859L (no) Nanopartikulaere formuleringer av docetaxel og analoger derav
EP2298304A3 (fr) Dérivés de carboline utiles pour le traitement du cancer
UA118645C2 (uk) Спосіб комбінованої терапії раку наночастинками, що містять рапаміцин і альбумін
AR056801A1 (es) Terapia combinada anti- proliferativa con determinados agentes quimioterapeuticos basados en platino e inhibidores de egfr o analogos de pirimidina
CL2008002224A1 (es) Composicion farmaceutica que comprende a) un compuesto seleccionado entre paclitaxel, docetaxel, ispinesib, tiazoloquinolina, entre otro, y b) compuestos inhibidores de aurora quinasa seleccionados entre derivados de imidazopirazina; uso de combinacion y de la composicion para tratar el cancer.
RS20080167A (en) Novel improved compositions for cancer therapy
EA201690265A2 (ru) Фармацевтические композиции, содержащие замещенные ациланилиды
MX2007006204A (es) Combinaciones que comprenden inhibidores de jak y cuando menos uno de entre inhibidores de bcr-abl, flt-3, fak o raf cinasa.
HK1118019A1 (zh) 用於治療癌症的包含ω-羧芳基取代的二苯基脲的藥物組合物
IL220043A0 (en) Methods for producing ??-galactosidase a compositions
IL184051A (en) Acetylated GLP-1 compounds, containing and using pharmaceutical preparations
MX2015011752A (es) Metodos para tratar cancer de pulmon.
NO20072179L (no) Kombinasjon av en SRC kinase inhibitor og en. BCR-ABL inhibitor for behandling av proleferative sykdommer
BRPI0416268A (pt) composições de delta-9-thc e métodos para o tratamento de sintomas associados à esclerose múltipla
MX2008015775A (es) Compuestos y composiciones para tratamiento de cancer.
TW200716088A (en) Formulations and methods for treating amyloidosis
WO2005085188A3 (fr) Composes et procedes pour la therapie antitumorale
MX2018007772A (es) Terapia de combinacion.
IL200410A0 (en) Novel derivatives of psammaplin a, a method for their synthesis and their use for the prevention or treatment of cancer
EP1503748A4 (fr) Medicaments servant a attenuer la neurotoxicite induite par le taxane
WO2007076160A3 (fr) Carbamates c-10 de taxanes
NO20080037L (no) Kombinasjon av pyrimidylaminobenzamidforbindelser og imatinib for behandling eller forbyggelse av proliferative sykdommer
HK1102626A1 (en) Compositions and methods for the treatment and prevention of hyperproliferative diseases

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application